Abstract
Without direct comparison or randomized controlled trials, two experts square off on the difficult choice of trying to reduce the usage of one of two drugs with well-known side effects after kidney transplantation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3026-3030 |
| Number of pages | 5 |
| Journal | Journal of the American Society of Nephrology |
| Volume | 18 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2007 |